The Medical Device Credit is equal to 100% of the user fees actually paid to the United States Food and Drug Administration (FDA) by a medical device company during the taxable year for which the tax is due for premarket submissions to market new technologies or upgrades, changes, or enhancements to existing technologies, developed or manufactured in Massachusetts.

Origin: M.G.L. c. 63, § 31L; c. 62, § 6½

Item Number
FY2020
FY2021
FY2022
FY2023
FY2024
1.613
Negligible
Negligible
Negligible
Negligible
Negligible
Loading...